Free shipping on all orders over $ 500

XMD8-92

Cat. No. M6089

All AbMole products are for research use only, cannot be used for human consumption.

XMD8-92 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 54  USD54 In stock
5mg USD 48  USD48 In stock
10mg USD 70  USD70 In stock
50mg USD 250  USD250 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

XMD8-92, via inhibition of BMK1 activation, significantly induces p21 expression in cells, and mediates suppression of cancer cell proliferation. XMD8-92 markedly abrogates the inhibitive effects of hydroxysafflor yellow A (HSYA) on hepatic stellate cell (HSC) activation, and blockes the HSYA-mediated MEF2C down-regulation.

Protocol (for reference only)
Cell Experiment
Cell lines A549 cell lines
Preparation method Control and shBNIP3/shBNIP3L A549 sphere cells were treated with/without 4 μmol/L XMD8-92 for 36 hrs, and collected by trypsinization and centrifugation at 300 G for 5 mins. The resultant cells were washed twice with cold PBS and resuspended in 100 μL Annexin-binding buffer.
Concentrations 4 μmol/L
Incubation time 36 h
Animal Experiment
Animal models Nod/Scid mice bearing HeLa xenograft, C57Bl/6 mice bearing LL/2 xenograft
Formulation
Dosages ~50 mg/kg twice a day
Administration i.p.
Chemical Information
Molecular Weight 474.55
Formula C26H30N6O3
CAS Number 1234480-50-2
Solubility (25°C) DMSO 48 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Park SJ, et al. Cancer Lett. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.

[2] Song C, et al. Oncotarget. Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L.

[3] Sureban SM, et al. Cancer Lett. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.

Related ERK Products
ERK Inhibitor II (Negative control) 

ERK Inhibitor II (Negative control) is an effective inhibitor of extracellular signal-regulated kinase (ERK).

PACAP-38 (31-38), human, mouse, rat

PACAP-38 (31-38), human, mouse, rat is a PAC1 receptor activator and increases the α-secretase activity.

Endothelin-1 (1-31) (Human)

Endothelin-1 (1-31) (Human) is a potent vasoconstrictor and hypertensive agent.

ZINC12409120

ZINC12409120 is a high selective ERK inhibitor.

Tizaterkib (hexanedioic acid)

Tizaterkib hexanedioic acid is a potent and selective ERK2 inhibitor, with an IC50 of 0.6 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: XMD8-92 supplier, ERK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.